Skip to main content
. 2015 Aug 17;51(2):66–80. doi: 10.4068/cmj.2015.51.2.66

TABLE 3. A summary of double-blind, randomized, placebo-controlled clinical trials (RCTs) of aripiprazole augmentation.

graphic file with name cmj-51-66-i003.jpg

MADRS: Montgomery-Åsberg Depression Rating Scale, ARP: aripiprazole, PBO: placebo, ap<0.05, ARP vs PBO, otherwise not significant, bIdentical RCT and analyzed differently on primary objective.